What's in InventisBio Co., Ltd's pipeline?

InventisBio Co., Ltd has 8 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 1 in Phase 2, 4 in Phase 1.

Which companies overlap with InventisBio Co., Ltd's portfolio?

Top competitors by shared drug class: Jiangsu HengRui Medicine Co., Ltd., AstraZeneca, Balmoral Medical company, Ahn-Gook Pharmaceuticals Co.,Ltd, Addpharma Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/inventisbio-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

InventisBio Co., Ltd — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

InventisBio Co., Ltd pipeline: 0 marketed, 0 filed, 3 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 1 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
D-1553	D-1553	phase 3	PI3K inhibitor	PI3K	Oncology
D-0502	D-0502	phase 3	small molecule	unknown	Oncology
D-2570	D-2570	phase 3	PI3K inhibitor	PI3K	Oncology

Therapeutic area mix

Oncology · 3
Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Jiangsu HengRui Medicine Co., Ltd. · 2 shared drug classes
AstraZeneca · 2 shared drug classes
Balmoral Medical company · 2 shared drug classes
Ahn-Gook Pharmaceuticals Co.,Ltd · 2 shared drug classes
Addpharma Inc. · 2 shared drug classes
Amorphical Ltd. · 1 shared drug class
AmMax Bio, Inc. · 1 shared drug class
Angitia Incorporated Limited · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for InventisBio Co., Ltd:

Cite this brief

Drug Landscape (2026). InventisBio Co., Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/inventisbio-co-ltd. Accessed 2026-06-10.